PURE Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
PURE Bioscience, Inc. (PURE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 60.00 thousand shares for the 6-month period ending 2021-01-31, per its 10-Q filed 2021-03-15.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2021-03-15
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-07-31 was 1.31M shares.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-04-30 was 0.00 shares, a 100.00% decline year-over-year.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-01-31 was 865.00K shares.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-10-31 was 375.00K shares, a 275.00% increase year-over-year.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 2.55M shares, a 750.00% increase from fiscal 2019.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 300.00K shares, a 86.64% decline from fiscal 2018.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 2.25M shares, a 39.89% decline from fiscal 2017.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 3.73M shares, a 101.89% increase from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2021-01-31 | 60.00K shares 10-Q · filed 2021-03-15 | |||
| 2020-07-31 | 1.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-08 | 1.31M shares derived: sum of 2 quarters · filed 2020-10-08 | 2.17M shares derived: sum of 3 quarters · filed 2020-10-08 | 2.55M shares 10-K · filed 2020-10-08 |
| 2020-04-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-11 | 865.00K shares derived: sum of 2 quarters · filed 2020-06-11 | 1.24M shares 10-Q · filed 2020-06-11 | 1.24M shares derived: sum of 4 quarters · filed 2020-10-08 |
| 2020-01-31 | 865.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-03-12 | 1.24M shares 10-Q · filed 2020-03-12 | 1.24M shares derived: sum of 3 quarters · filed 2020-10-08 | 1.44M shares derived: sum of 4 quarters · filed 2020-10-08 |
| 2019-10-31 | 375.00K shares 10-Q · filed 2019-12-13 | 375.00K shares derived: sum of 2 quarters · filed 2020-10-08 | 575.00K shares derived: sum of 3 quarters · filed 2020-10-08 | 575.00K shares derived: sum of 4 quarters · filed 2020-10-08 |
| 2019-07-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-08 | 200.00K shares derived: sum of 2 quarters · filed 2020-10-08 | 200.00K shares derived: sum of 3 quarters · filed 2020-10-08 | 300.00K shares 10-K · filed 2020-10-08 |
| 2019-04-30 | 200.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-06-13 | 200.00K shares derived: sum of 2 quarters · filed 2019-06-13 | 300.00K shares 10-Q · filed 2019-06-13 | 500.00K shares derived: sum of 4 quarters · filed 2019-10-30 |
| 2019-01-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-03-06 | 100.00K shares 10-Q · filed 2019-03-06 | 300.00K shares derived: sum of 3 quarters · filed 2019-10-30 | 1.95M shares derived: sum of 4 quarters · filed 2019-10-30 |
| 2018-10-31 | 100.00K shares 10-Q · filed 2018-12-13 | 300.00K shares derived: sum of 2 quarters · filed 2019-10-30 | 1.95M shares derived: sum of 3 quarters · filed 2019-10-30 | 2.15M shares derived: sum of 4 quarters · filed 2019-10-30 |
| 2018-07-31 | 200.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-30 | 1.84M shares derived: sum of 2 quarters · filed 2019-10-30 | 2.04M shares derived: sum of 3 quarters · filed 2019-10-30 | 2.25M shares 10-K · filed 2019-10-30 |
| 2018-04-30 | 1.65M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-06-13 | 1.84M shares derived: sum of 2 quarters · filed 2018-06-13 | 2.04M shares 10-Q · filed 2018-06-13 | 4.04M shares derived: sum of 4 quarters · filed 2018-10-25 |
| 2018-01-31 | 200.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-03-14 | 400.00K shares 10-Q · filed 2018-03-14 | 2.40M shares derived: sum of 3 quarters · filed 2018-10-25 | 4.04M shares derived: sum of 4 quarters · filed 2018-10-25 |
| 2017-10-31 | 200.00K shares 10-Q · filed 2017-12-14 | 2.20M shares derived: sum of 2 quarters · filed 2018-10-25 | 3.83M shares derived: sum of 3 quarters · filed 2018-10-25 | 3.83M shares derived: sum of 4 quarters · filed 2018-10-25 |
| 2017-07-31 | 2.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-25 | 3.63M shares derived: sum of 2 quarters · filed 2018-10-25 | 3.63M shares derived: sum of 3 quarters · filed 2018-10-25 | 3.73M shares 10-K · filed 2018-10-25 |
| 2017-04-30 | 1.64M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-06-08 | 1.64M shares derived: sum of 2 quarters · filed 2017-06-08 | 1.74M shares 10-Q · filed 2017-06-08 | 2.73M shares derived: sum of 4 quarters · filed 2017-10-26 |
| 2017-01-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-03-02 | 100.00K shares 10-Q · filed 2017-03-02 | 1.10M shares derived: sum of 3 quarters · filed 2017-10-26 | |
| 2016-10-31 | 100.00K shares 10-Q · filed 2016-12-14 | 1.10M shares derived: sum of 2 quarters · filed 2017-10-26 | ||
| 2016-07-31 | 1.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-26 | 1.85M shares 10-K · filed 2017-10-26 | ||
| 2016-04-30 | 850.00K shares 10-Q · filed 2016-06-09 | |||
| 2015-10-31 | 0.00 shares 10-Q · filed 2015-12-10 | |||
| 2015-04-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-06-11 | 0.00 shares derived: sum of 2 quarters · filed 2015-06-11 | 0.00 shares 10-Q · filed 2015-06-11 | |
| 2015-01-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-03-04 | 0.00 shares 10-Q · filed 2015-03-04 | ||
| 2014-10-31 | 0.00 shares 10-Q · filed 2015-12-10 | |||
| 2013-10-31 | 0.00 shares 10-Q · filed 2013-12-12 | |||
| 2013-04-30 | 40.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-06-14 | 273.00K shares derived: sum of 2 quarters · filed 2013-06-14 | 273.00K shares 10-Q · filed 2013-06-14 | |
| 2013-01-31 | 233.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-25 | 233.00K shares 10-Q · filed 2013-02-25 | ||
| 2012-10-31 | 0.00 shares 10-Q · filed 2013-12-12 |